Safety and tolerability of an injectable diagnostic radiopharmaceutical (68Ga-DOTATOC) in patients with proven gastro-entero-pancreatic neuroendocrine tumors

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002741-21

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the safety and tolerability of a single administration of 2 MBq/kg - but not less than 100 MBq - of 68Ga-DOTATOC in patients suffering from gastro-entero-pancreatic neuroendocrine tumours.


Critère d'inclusion

  • Patients with proven gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs)

Liens